# | Aladdin ID | Assay Type | Description | Organism | Compounds | Reference | BAO Format | Source | |
---|---|---|---|---|---|---|---|---|---|
1. | ALA909202 | F | Antitumor activity against human jurkat cell line by MTT assay | Homo sapiens | 13 | cell-based format | Scientific Literature | ||
2. | ALA909204 | F | Antitumor activity against human A2780 cell line by RTCES assay | Homo sapiens | 17 | cell-based format | Scientific Literature | ||
3. | ALA909688 | F | Antitumor activity against human OVACR4 cell line by RTCES assay | Homo sapiens | 17 | cell-based format | Scientific Literature | ||
4. | ALA909689 | F | Antitumor activity against human HT1080 cell line by RTCES assay | Homo sapiens | 17 | cell-based format | Scientific Literature | ||
5. | ALA909690 | F | Antitumor activity against human H460 cell line by RTCES assay | Homo sapiens | 17 | cell-based format | Scientific Literature | ||
6. | ALA909691 | F | Antitumor activity against human MCF7 cell line by RTCES assay | Homo sapiens | 17 | cell-based format | Scientific Literature | ||
7. | ALA909692 | F | Antitumor activity against human M231 cell line by RTCES assay | Homo sapiens | 17 | cell-based format | Scientific Literature | ||
8. | ALA909693 | F | Antitumor activity against human HeLa cell line by RTCES assay | Homo sapiens | 13 | cell-based format | Scientific Literature | ||
9. | ALA909694 | F | Antitumor activity against human HepG2 cell line by RTCES assay | Homo sapiens | 17 | cell-based format | Scientific Literature | ||
10. | ALA3539432 | P | Drug metabolism in phosphate buffered saline assessed as p-FBM metabolite formation at 5 uM by HPLC analysis in presence of GSH | 1 | small-molecule physicochemical format | Scientific Literature | |||
11. | ALA3539433 | P | Drug metabolism in phosphate buffered saline assessed as p-FBM metabolite formation at 5 uM by HPLC analysis in presence of cysteine | 1 | small-molecule physicochemical format | Scientific Literature | |||
12. | ALA3539434 | P | Drug metabolism in phosphate buffered saline assessed as p-FBM metabolite formation at 5 uM by HPLC analysis in presence of N-acetyl cysteine | 1 | small-molecule physicochemical format | Scientific Literature | |||
13. | ALA3539435 | P | Drug metabolism in phosphate buffered saline assessed as p-FBM metabolite formation at 5 uM by HPLC analysis in presence of coenzyme A | 1 | small-molecule physicochemical format | Scientific Literature | |||
14. | ALA3539440 | P | Stability of compound in phosphate buffered saline at 5 uM after 30 mins by HPLC analysis in presence of GSH | 1 | small-molecule physicochemical format | Scientific Literature | |||
15. | ALA3539441 | P | Stability of compound in phosphate buffered saline at 5 uM after 30 mins by HPLC analysis in presence of cysteine | 1 | small-molecule physicochemical format | Scientific Literature | |||
16. | ALA3539442 | P | Stability of compound in phosphate buffered saline at 5 uM after 30 mins by HPLC analysis in presence of N-acetyl cysteine | 1 | small-molecule physicochemical format | Scientific Literature | |||
17. | ALA3539443 | P | Stability of compound in phosphate buffered saline at 5 uM after 30 mins by HPLC analysis in presence of coenzyme A | 1 | small-molecule physicochemical format | Scientific Literature | |||
18. | ALA3539444 | A | Stability in Sprague-Dawley rat RBC at 5 uM incubated for 1 hr after 5 mM thiol residue blocking agent iodoacetamide challenge by HPLC analysis | Rattus norvegicus | 1 | cell-based format | Scientific Literature | ||
19. | ALA3539445 | P | Drug metabolism in phosphate buffered saline assessed as GSH-p-FBM metabolite formation at 5 uM after 30 mins by LC-MS analysis in presence of GSH | 1 | small-molecule physicochemical format | Scientific Literature | |||
20. | ALA3539447 | A | Drug metabolism in Sprague-Dawley rat RBC assessed as BFBDS metabolite formation by HPLC analysis | Rattus norvegicus | 3 | cell-based format | Scientific Literature |